Supply Chain | May 02, 2026
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The company posted revenue of €1,267 million, up 6% on a constant currency basis
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Targets high-growth eye care expansion push
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
